Biesterfeld and Omya conclude an agreement for the distribution of natural and functionalized calcium carbonates for the pharmaceutical and nutraceutical sectors in Germany and Austria

Biesterfeld Spezialchemie is entering into a distribution partnership with Omya, the leading producer of calcium carbonate-based specialties. The collaboration covers the pharmaceutical and nutraceutical sectors. With immediate effect Biesterfeld will distribute the Swiss manufacturer's innovative excipients and active ingredients Omyapure®, Calcipur® DC and Omyapharm®. The new agreement applies in Germany and Austria.

Thanks to the new distribution partnership, the product portfolio will be expanded to include innovative pharmaceutical excipients and active ingredients, as well as products for nutraceuticals. These include Omyapure®, a natural calcium carbonate used as a pharmaceutical active ingredient, for example as an acid blocker or for the prevention of osteoporosis. Calcipur® DC is a directly compressible calcium carbonate, used in the nutraceutical sector as an excipient in the manufacture of tablets and characterised by its ease of use.

Omyapharm® is an innovative, multifunctional pharmaceutical excipient (co-processed excipient), used in the manufacture of solid dosage forms (tablets, capsules, granules) in the pharmaceutical industry. Omyapharm® delivers remarkable results in terms of compactability and its ability to absorp  liquids. The combination of high hardness together with its fast disintegration is particularly impressive. Thus, orodispersible tablets (ODTs) made with Omyapharm®  particularly dissolve in the mouth within  only few seconds. As a result of these outstanding properties, the product was awarded in 2015 with the CPhI Innovation Award as thebest Innovation in APIs and Excipients.

"Biesterfeld will be a strong and reliable partner for us. With their proven experience in the pharmaceutical sector and technology-based consulting, Biesterfeld's experts can offer a comprehensive range of services. These are the optimum prerequisites for placing our products on the market in the best possible way and to develop the business together," says Dr. Javier Camargo, Global Business Development Manager, Pharmaceuticals and Nutraceuticals, at Omya.

"We are very pleased about the trust our partner Omya has placed in us with these distribution rights," says Dr. Andreas Lekebusch, HealthCare Business Manager at Biesterfeld Spezialchemie. "This partnership allows us to significantly expand our product portfolio with active ingredients and the innovative excipient Omyapharm® and we are very pleased to be able to provide our customers with comprehensive advice and support in the development of solid dosage forms."

About Omya

Omya is a leading global producer of calcium carbonates and a worldwide distributor of specialty additives, premium services and solutions. Founded in 1884 in Switzerland, Omya has a global presence extending to more than 175 locations in over 50 countries with 8,000 employees. Omya provides sustainable added value products and services from responsibly sourced materials to meet the needs of current and future generations. In the Consumer Goods sector, Omya offers innovative solutions based on high purity natural minerals and complementary ingredients that comply with the most stringent regulatory and quality standards.

For further information, please visit: www.omya.com

Product contact

Monja Lampert
Ferdinandstrasse 41
20095 Hamburg
Phone: +49 40 32008-601

Logo Biesterfeld AG

Press Contact

Biesterfeld AG, Eva Switala

Contact Person

Eva Switala

Spokesperson HealthCare | Performance Products | Nutrition


Biesterfeld AG, Melanie Lang

Contact Person

Melanie Lang

Spokesperson LifeScience | CASE | Polymer Additives